Breaking News
FDA Approves “Glowing Tumor” Imaging Drug to Aid Lung Cancer Surgery
[ad_1] Newswise — PHILADELPHIA—The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable…